The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

That changed in August, when a new FDA-approved blood test to detect colorectal cancer became available at doctor’s offices. Now, a new study has spotlighted that blood test, called the Shield ...

But now, researchers have developed a new test that can diagnose Parkinson ... They’ve developed a simple blood test that can precisely diagnose Parkinson’s disease sometimes before symptoms ...

“The FDA’s approval of the Shield blood test marks a tremendous leap forward, offering a compelling new solution to close this gap,” Chung said in a statement. “This decision will help ...

New blood-based and stool-based screening tests, including the cell-free DNA blood test (cf-bDNA), are commercially available at $1495. The development of different screening methods has raised ...

it’s therefore really encouraging that this new blood test from Roche could help rule out Alzheimer’s disease for people who are experiencing memory issues and could be another tool to ...

Blood tests for colorectal cancer are an option for patients who would otherwise not be screened, but they are not as effective as colonoscopies or stool tests, a Stanford Medicine-led study found.

The test only detected precancerous polyps in about 13% of patients. A new study published Oct. 28 determined that death rates for patients undergoing blood tests are much higher than patients ...